Dorraya El‐Ashry

4.1k citations

52 papers · 3.1k indexed · h-index 31

Molecular Biology top 5%
Oncology top 1%
Cancer Research top 2%
Genetics top 2%
Immunology top 10%

Co-authors: Florian Kern Marc E. Lippman Gabriela Dontu Max S. Wicha Joyce M. Slingerland Chad J. Creighton David L. Miller Jamie N. Holloway
Topics: Cancer Cells and Metastasis (17 papers)Estrogen and related hormone effects (14 papers)HER2/EGFR in Cancer Research (12 papers)
Cited by: Cancer Research Oncology Genetics
Journals: Cancer Research Oncogene Clinical Cancer Research
Partner nations: United States United Kingdom Spain

In The Last Decade

Dorraya El‐Ashry

51 papers receiving 3.1k citations

Peers

Countries citing papers authored by Dorraya El‐Ashry

Since Specialization

Citations

This map shows the geographic impact of Dorraya El‐Ashry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorraya El‐Ashry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorraya El‐Ashry more than expected).

Fields of papers citing papers by Dorraya El‐Ashry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorraya El‐Ashry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorraya El‐Ashry. The network helps show where Dorraya El‐Ashry may publish in the future.

Co-authorship network of co-authors of Dorraya El‐Ashry

This figure shows the co-authorship network connecting the top 25 collaborators of Dorraya El‐Ashry. A scholar is included among the top collaborators of Dorraya El‐Ashry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorraya El‐Ashry. Dorraya El‐Ashry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds 2019 ·npj Breast Cancer ·Yvonne Ziegler,Mary J. Laws,Valeria Sanabria Guillen,Sung Hoon Kim,Parama Dey,Brandi Patrice Smith,Ping Gong,(unknown),Yuechao Zhao,Kathryn E. Carlson,(unknown),Divya Singh,Zhong Li,Dorraya El‐Ashry,Zeynep Madak‐Erdogan,John A. Katzenellenbogen,Benita S. Katzenellenbogen	62
2	VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug 2017 ·Oncogene ·(unknown),Keum‐Il Jang,Philip Miller,Manuel Picon‐Ruiz,Toni M. Yeasky,Dorraya El‐Ashry,Joyce M. Slingerland	81
3	Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b–Mediated Malignant Progression 2016 ·Cancer Research ·Manuel Picon‐Ruiz,(unknown),Katherine Drews‐Elger,Kibeom Jang,Alexandra H. Besser,Dekuang Zhao,Cynthia Morata‐Tarifa,(unknown),Tan A. Ince,Diana J. Azzam,Seth A. Wander,Bin Wang,(unknown),Ram H. Datar,Richard J. Côté,Guy A. Howard,Dorraya El‐Ashry,(unknown),Juan Antonio Marchal,Joyce M. Slingerland	143
4	MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer 2015 ·Clinical Cancer Research ·(unknown),Philip C. Miller,Dorraya El‐Ashry,Jun Sun,Alexandra H. Besser,Tan A. Ince,Mengnan Gu,Zhi Wei,Gao Zhang,Patricia Brafford,Wei Gao,Yiling Lu,Gordon B. Mills,Joyce M. Slingerland,Fiona Simpkins	46
5	Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype 2015 ·Cancer Biology & Therapy ·Sanket H. Shah,Philip Miller,Marta García-Contreras,Zheng Ao,(unknown),(unknown),Dorraya El‐Ashry	54
6	A Novel MAPK–microRNA Signature Is Predictive of Hormone-Therapy Resistance and Poor Outcome in ER-Positive Breast Cancer 2014 ·Clinical Cancer Research ·Philip C. Miller,Jennifer Clarke,Tulay Koru‐Sengul,Joeli Brinkman,Dorraya El‐Ashry	37
7	Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures 2014 ·Breast Cancer Research and Treatment ·Katherine Drews‐Elger,Joeli Brinkman,Philip Miller,Sanket H. Shah,J. Chuck Harrell,(unknown),Zheng Ao,(unknown),Diana J. Azzam,Kathleen M. Diehl,Dafydd G. Thomas,Joyce M. Slingerland,Charles M. Perou,Marc E. Lippman,Dorraya El‐Ashry	31
8	VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2 2014 ·Oncogene ·Dekuang Zhao,(unknown),Junjun Sun,Candace A. Gilbert,Katherine Drews‐Elger,Diana J. Azzam,Manuel Picon‐Ruiz,(unknown),(unknown),Dorraya El‐Ashry,Chad J. Creighton,Joyce M. Slingerland	219
9	MSC-Regulated MicroRNAs Converge on the Transcription Factor FOXP2 and Promote Breast Cancer Metastasis 2014 ·Cell stem cell ·Benjamin Cuiffo,Antoine Campagne,George W. Bell,Antonio Lembo,Francesca Orso,Evan C. Lien,Manoj Bhasin,Monica Raimo,Summer E. Hanson,Andriy Marusyk,Dorraya El‐Ashry,Peiman Hematti,Kornélia Polyák,Fatima Mechta‐Grigoriou,Odette Mariani,Stefano Volinia,Anne Vincent‐Salomon,Daniela Taverna,Antoine E. Karnoub	143
10	Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody 2009 ·Breast Cancer Research and Treatment ·H. James Hnatyszyn,(unknown),(unknown),Lynn M. Herbert,Carmen Gomez‐Fernandez,Mercè Jordà,Dafydd G. Thomas,James M. Rae,Dorraya El‐Ashry,Marc E. Lippman	21
11	ER Re-expression and Re-sensitization to Endocrine Therapies in ER-negative Breast Cancers 2009 ·Journal of Mammary Gland Biology and Neoplasia ·Joeli Brinkman,Dorraya El‐Ashry	52
12	A Phase II Trial of ISIS 3521 in Patients with Metastatic Colorectal Cancer 2004 ·Clinical Colorectal Cancer ·John L. Marshall,(unknown),Michael D. Johnson,John Hanfelt,F. Andrew Dorr,Dorraya El‐Ashry,Michael D. Oberst,(unknown),Jon Holmlund,Shakun Malik	28
13	Estrogen Receptor Expression and Sensitivity to Paclitaxel in Breast Cancer 2004 ·Cancer Biology & Therapy ·M. K. Dougherty,Lisa M. Schumaker,V. Craig Jordan,Wade V. Welshons,Edward M. Curran,Matthew J. Ellis,Dorraya El‐Ashry	20
14	Breast cancer, stem/progenitor cells and the estrogen receptor 2004 ·Trends in Endocrinology and Metabolism ·Gabriela Dontu,Dorraya El‐Ashry,Max S. Wicha	233
15	Use of ERE and Reporter Gene Constructs to Assess Putative Estrogenic Activity 1999 ·Journal of Medicinal Food ·Robert Clarke,Todd C. Skaar,Dorraya El‐Ashry,Fabio Leonessa,Leena Hilakivi‐Clarke	0
16	Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells 1999 ·Oncogene ·Sharyl J. Nass,Anne Ferguson,Dorraya El‐Ashry,William G. Nelson,Nancy E. Davidson	33
17	Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis 1997 ·Oncogene ·Dorraya El‐Ashry,David L. Miller,Samir Kharbanda,Marc E. Lippman,Florian Kern	83
18	Estrogen induction of TGF-α is mediated by an estrogen response element composed of two imperfect palindromes 1996 ·The Journal of Steroid Biochemistry and Molecular Biology ·Dorraya El‐Ashry,Susan A. Chrysogelos,Marc E. Lippman,Florian Kern	58
19	Mapping Contacts between Unpurified Human Progesterone Receptor and the Hormone Response Element of Mouse Mammary Tumor Virus 1989 ·DNA ·B. Kühnel,Dorraya El‐Ashry,Dean P. Edwards,Steven K. Nordeen	4
20	Human Progesterone Receptor Complexed with the Antagonist RU 486 Binds to Hormone Response Elements in a Structurally Altered Form 1989 ·Molecular Endocrinology ·Dorraya El‐Ashry,Sergio A. Oñate,Steven K. Nordeen,Dean P. Edwards	119

About Dorraya El‐Ashry

Dorraya El‐Ashry is a scholar working on Oncology, Cancer Research and Genetics, having authored 52 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (17 papers), Estrogen and related hormone effects (14 papers) and HER2/EGFR in Cancer Research (12 papers). The work is most often cited by research in Cancer Research (972 citations), Oncology (1.7k citations) and Genetics (789 citations). Dorraya El‐Ashry has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Florian Kern, Marc E. Lippman, Gabriela Dontu, Max S. Wicha, Joyce M. Slingerland, Chad J. Creighton, David L. Miller, Jamie N. Holloway, Shalini Murthy and Katherine Drews‐Elger. Their work appears in journals such as Cancer Research, Oncogene and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact